Skip to main content
. Author manuscript; available in PMC: 2014 Jul 22.
Published in final edited form as: Arthritis Rheumatol. 2014 Jan;66(1):130–139. doi: 10.1002/art.38204

Table 5.

Associations of the PREDICTS variables with the presence of any carotid plaque on baseline or longitudinal ultrasound in patients with systemic lupus erythematosus*

Explanatory variable Odds ratio 95% CI P
History of dyslipidemia (yes, no) 3.2 1.06–9.8 0.04
Hypertension (yes, no) 0.8 0.3–2.0 NS
Current tobacco use (yes, no) 1.6 0.3–7.5 NS
Family history of cardiovascular disease (yes, no) 1.3 0.5–3.2 NS
Body mass index (in kg/m2) 1.01 0.95–1.07 NS
African American race (yes, no) 4.6 1.1–18.6 0.03
Lifetime prednisone use >20 gm (yes, no) 0.6 0.2–1.7 NS
Initiation of statin therapy (yes, no) 0.7 0.2–2.5 NS
Disease duration 1.03 0.98–1.09 NS
High PREDICTS score (yes, no) 27.7 10.6–72.7 <0.001
*

Associations were determined by logistic regression. 95% CI = 95% confidence interval; NS = not significant.

Variables include age ≥48 years, proinflammatory high-density lipoprotein levels ≥0.94 fluorescence units, leptin levels ≥34 ng/ml, soluble TWEAK levels ≥373 pg/ml, and homocysteine levels ≥12 μmoles/liter. A high Predictors of Risk for Elevated Flares, Damage Progression, and Increased Cardiovascular Disease in Patients with Systemic Lupus Erythematosus (PREDICTS) score was defined as the presence of ≥3 of the risk factors or history of diabetes plus ≥1 of the risk factors.